Terms: = Lymphoma AND HERPUD1, ENSG00000051108, 9709, Q15011, SUP, Mif1, KIAA0025, HERP AND Treatment
66 results:
1. Raman classification of selected subtypes of acute lymphoblastic leukemia (ALL).
Adamczyk A; Nowakowska AM; Jakubowska J; Zabczynska M; Bartoszek M; Kashyrskaya S; Fatla A; Stawoski K; Siakala K; Pastorczak A; Ostrowska K; Mlynarski W; Majzner K; Baranska M
Analyst; 2024 Jan; 149(2):571-581. PubMed ID: 38099606
[TBL] [Abstract] [Full Text] [Related]
2. Resistance to the BCL-XL degrader DT2216 in T-cell acute lymphoblastic leukemia is rare and correlates with decreased BCL-XL proteolysis.
Jaiswal A; Jaiswal A; Williamson EA; Gelfond J; Zheng G; Zhou D; Hromas R
Cancer Chemother Pharmacol; 2023 Jan; 91(1):89-95. PubMed ID: 36346454
[TBL] [Abstract] [Full Text] [Related]
3.
Van Trimpont M; Schalk AM; De Visser Y; Nguyen HA; Reunes L; Vandemeulebroecke K; Peeters E; Su Y; Lee H; Lorenzi PL; Chan WK; Mondelaers V; De Moerloose B; Lammens T; Goossens S; Van Vlierberghe P; Lavie A
Haematologica; 2023 Feb; 108(2):409-419. PubMed ID: 35979719
[TBL] [Abstract] [Full Text] [Related]
4. Netrin-1 induces the anti-apoptotic and pro-survival effects of B-ALL cells through the Unc5b-MAPK axis.
Huang L; An X; Zhu Y; Zhang K; Xiao L; Yao X; Zeng X; Liang S; Yu J
Cell Commun Signal; 2022 Aug; 20(1):122. PubMed ID: 35974411
[TBL] [Abstract] [Full Text] [Related]
5. Impact of
Ruel NM; Nguyen KH; Kim CS; Andrade LPS; Hammond JR
J Pharmacol Exp Ther; 2022 Sep; 382(3):335-345. PubMed ID: 35798387
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of Skp2 enhances doxorubicin-induced cell death in B cell precursor acute lymphoblastic leukemia.
Manafi Shabestari R; Chegeni R; Faranoush M; Zaker F; Safa M
Cell Biol Int; 2022 Jun; 46(6):895-906. PubMed ID: 35143089
[TBL] [Abstract] [Full Text] [Related]
7. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
Hui PY; Chen YH; Qin J; Jiang XH
Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
[TBL] [Abstract] [Full Text] [Related]
8. Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia.
Durmaz B; Bagca BG; Cogulu O; Susluer SY; Alpay A; Aksoylar S; Gunduz C
Biomed Res Int; 2021; 2021():3207328. PubMed ID: 34877353
[TBL] [Abstract] [Full Text] [Related]
9. treatment results of modified BFM protocol in pediatric high-risk Burkitt lymphoma.
Vural S; Genç DB; Kebudi R; Doğan Ö; Karaman S
Turk J Pediatr; 2021; 63(4):639-647. PubMed ID: 34449146
[TBL] [Abstract] [Full Text] [Related]
10. Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
Mohseni M; Kucharski C; K C RB; Nasrullah M; Jiang X; Uludağ H; Brandwein J
PLoS One; 2021; 16(6):e0251719. PubMed ID: 34157051
[TBL] [Abstract] [Full Text] [Related]
11. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
Zhang MY; Wang LQ; Chim CS
Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
[TBL] [Abstract] [Full Text] [Related]
12. [Effect of Huaier Aqueous Extract Combined with Routine Chemo-therapeutic Drugs on Human Acute Lymphoblastic Leukemia Cells Nalm-6 and sup-B15].
Qu P; Zhou F; Tan LF; Wang ZJ; Wang ML; Jin RM; Han J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1451-1458. PubMed ID: 33067936
[TBL] [Abstract] [Full Text] [Related]
13. HDAC3 Silencing Enhances Acute B Lymphoblastic Leukaemia Cells Sensitivity to MG-132 by Inhibiting the JAK/Signal Transducer and Activator of Transcription 3 Signaling Pathway.
Guo Y; Li X; He Z; Ma D; Zhang Z; Wang W; Xiong J; Kuang X; Wang J
Chemotherapy; 2020; 65(3-4):85-100. PubMed ID: 32966974
[TBL] [Abstract] [Full Text] [Related]
14. CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph+ ALL sup‑B15 cells.
Xing C; Xu W; Shi Y; Zhou B; Wu D; Liang B; Zhou Y; Gao S; Feng J
Mol Med Rep; 2020 Oct; 22(4):2791-2800. PubMed ID: 32945456
[TBL] [Abstract] [Full Text] [Related]
15. Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment.
Al-Aamri HM; Irving HR; Meehan-Andrews T; Bradley C
BMC Res Notes; 2019 Sep; 12(1):625. PubMed ID: 31551083
[TBL] [Abstract] [Full Text] [Related]
16. Huaier extract enhances the treatment efficacy of imatinib in Ik6
Qu P; Han J; Qiu Y; Yu H; Hao J; Jin R; Zhou F
Biomed Pharmacother; 2019 Sep; 117():109071. PubMed ID: 31202171
[TBL] [Abstract] [Full Text] [Related]
17. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
Al-Aamri HM; Ku H; Irving HR; Tucci J; Meehan-Andrews T; Bradley C
BMC Cancer; 2019 Feb; 19(1):179. PubMed ID: 30813936
[TBL] [Abstract] [Full Text] [Related]
18. A technique for total skin electron therapy (TSET) of an anesthetized pediatric patient.
Kron T; Donahoo G; Lonski P; Wheeler G
J Appl Clin Med Phys; 2018 Nov; 19(6):109-116. PubMed ID: 30267453
[TBL] [Abstract] [Full Text] [Related]
19. Down-regulation of CD19 expression inhibits proliferation, adhesion, migration and invasion and promotes apoptosis and the efficacy of chemotherapeutic agents and imatinib in sup-B15 cells.
Wu J; Liang B; Qian Y; Tang L; Xing C; Zhuang Q; Shen Z; Jiang S; Yu K; Feng J
Cell Biol Int; 2018 Sep; 42(9):1228-1239. PubMed ID: 29809305
[TBL] [Abstract] [Full Text] [Related]
20. Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure<sup/>.
Ludmir EB; Milgrom SA; Pinnix CC; Gunther JR; Westin J; Oki Y; Fayad LE; Medeiros LJ; Dabaja BS; Nastoupil LJ
Leuk Lymphoma; 2018 Dec; 59(12):2896-2903. PubMed ID: 29697005
[TBL] [Abstract] [Full Text] [Related]
[Next]
